I kept beating myself up, trying to figure out why the largest food/products company in the world put money in Navigenics. Was it for nutrigenomics? Was it for the captive audience to market products to?
Until today, when I read in American Medical news that Proctor and Gamble BOUGHT MDVIP in December of last year! Man how did I miss that one?
"Terms of P&G’s acquisition were not disclosed. It was made by P&G’s FutureWorks unit, a new-business generator that’s intended to connect the company with external partners and expand P&G’s scope beyond its core businesses into new channels."
So, P&G is looking for the whole enchilada in personalized medicine here.
Too bad, Navigenics' tests are currently not useful. But maybe someday they will be......
The Sherpa Says: Navigenics is not the target. MDVIP was, so don't believe anyone who tells you otherwise...
1 comment:
Aha! We finally caught you off guard! I should have sent you the link the day of the Navi investment last February! And, P&G also owns half a medical diagnostics company too! So, perhaps MDVIP isn't the sole focus/target? :)
Post a Comment